Leonard Azamfirei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Leonard Azamfirei has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Lenard Farczadi
Chromatography and Mass Spectrometry Laboratory, Centre for Advanced Medical and Pharmaceutical Research, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania
1 shared publication - Mihaela Butiulca
Department of Anesthesiology and Intensive Care Medicine, Faculty of General Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Târgu Mureș, Romania
1 shared publication - Mihaly Veres
Doctoral School, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania
1 shared publication
Latest Publications
- Open Access
- 9 March 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (3) , 439
Analytical Methods for Melatonin Quantification: Advances, Challenges, and Clinical Applications
Melatonin, an indoleamine crucial for regulating circadian rhythms, sleep–wake cycles, and immune–endocrine homeostasis, is present in biological fluids at extremely low concentrations, making its quantification analytically challenging. This narrative review provides a critical comparative assessment of current methodologies for melatonin determination across various biological matrices—plasma, urine, saliva, breast milk, and hair. The discussed techniques include immunoassays, colorimetric and spectrophotometric methods, chromatographic–mass spectrometric platforms (LC–MS/MS, UHPLC–MS/MS), and emerging biosensors. Each approach is evaluated regarding analytical sensitivity, specificity, reproducibility, cost, and clinical applicability. While immunoenzymatic and colorimetric techniques offer accessible, low-cost solutions for large-scale or preliminary studies, LC–MS/MS remains the benchmark for reference analysis, providing sub-picogram detection limits and multiplexing capability. However, its high cost, procedural complexity, and inter-laboratory variability limit routine implementation. New developments, including molecularly imprinted polymers, dispersive microextraction, and nanomaterial-based biosensors, suggest a shift toward hybrid, sustainable, and portable analytical platforms. By synthesizing recent methodological advances and identifying key limitations, this review aims to guide researchers and clinicians in selecting the most appropriate analytical approach for clinical, pharmacological, and circadian biomonitoring applications.
- 9 March 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (3) , 439
Open AccessAnalytical Methods for Melatonin Quantification: Advances, Challenges, and Clinical Applications
Melatonin, an indoleamine crucial for regulating circadian rhythms, sleep–wake cycles, and immune–endocrine homeostasis, is present in biological fluids at extremely low concentrations, making its quantification analytically challenging. This narrative review provides a critical comparative assessment of current methodologies for melatonin determination across various biological matrices—plasma, urine, saliva, breast milk, and hair. The discussed techniques include immunoassays, colorimetric and spectrophotometric methods, chromatographic–mass spectrometric platforms (LC–MS/MS, UHPLC–MS/MS), and emerging biosensors. Each approach is evaluated regarding analytical sensitivity, specificity, reproducibility, cost, and clinical applicability. While immunoenzymatic and colorimetric techniques offer accessible, low-cost solutions for large-scale or preliminary studies, LC–MS/MS remains the benchmark for reference analysis, providing sub-picogram detection limits and multiplexing capability. However, its high cost, procedural complexity, and inter-laboratory variability limit routine implementation. New developments, including molecularly imprinted polymers, dispersive microextraction, and nanomaterial-based biosensors, suggest a shift toward hybrid, sustainable, and portable analytical platforms. By synthesizing recent methodological advances and identifying key limitations, this review aims to guide researchers and clinicians in selecting the most appropriate analytical approach for clinical, pharmacological, and circadian biomonitoring applications.